Tag: Imfinzi

AstraZeneca’s PACIFIC-2 Phase 3 trial for Imfinzi in NSCLC falls short of primary endpoint

businessnewstoday- November 14, 2023

In the latest development in oncology research, AstraZeneca's PACIFIC-2 Phase III trial, involving Imfinzi (durvalumab) concurrently administered with platinum-based chemoradiotherapy (CRT), did not achieve statistical ... Read More

AstraZeneca’s IMFINZI/IMJUDO shows sustained OS in Phase 3 liver cancer study

businessnewstoday- June 29, 2023

AstraZeneca's IMFINZI (durvalumab) combined with IMJUDO (tremelimumab-actl) has demonstrated an enduring overall survival (OS) benefit in patients with advanced hepatocellular carcinoma (HCC), according to the ... Read More

AstraZeneca reports positive results for phase 2 COAST trial of oleclumab and monalizumab

pallavi123- September 18, 2021

AstraZeneca has reported positive results from the COAST phase 2 trial of its oleclumab or monalizumab in combination with Imfinzi (durvalumab) in patients with non-small ... Read More

CHMP recommends AstraZeneca lung cancer drug Imfinzi EMA approval

pharmanewsdaily- July 29, 2018

Update on Imfinzi EMA approval : The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive ... Read More